Literature DB >> 32064986

Retrospective Comparison of Endoscopic Versus Open Procedure for Mitral Valve Disease.

Qin Jiang1, Zhilan Wang2, Jing Guo1, Tao Yu1, Xiaoshen Zhang3, Shengshou Hu4.   

Abstract

OBJECTIVES: We investigated whether the totally video-assisted thoracoscopic mitral valve surgery provides superior clinical outcomes and less inflammatory injury reaction compared with conventional sternotomy.
METHODS: A total of 504 consecutive patients admitted for mitral valve surgery from May 2014 through May 2019 in a single center were retrospectively analyzed according to two distinct procedure approach: the totally video-assisted thoracoscopic approach (group A, n = 127) and standard median sternotomy (group B, n = 377). The primary end point was the durations of cardiopulmonary bypass, aortic cross-clamping, the ventilation time and intensive care unit of stay; the secondary endpoints included inflammation indexes like high sensitivity C-reactive protein, neutrophil-lymphocyte ratio and metabolic injury parameters cardiac Troponin and lactate.
RESULTS: There was only one in-hospital death due to diffuse intravascular coagulation in group A, but similar complications such as repair failure, re-thoracotomy and stroke in both groups. The durations of cardiopulmonary bypass and aortic cross-clamping were significantly longer in group A. In contrast, ventilation time and intensive care unit of stay were shortened compared with these in group B. In addition, postoperative equivalent lactate clearance but lower high sensitivity C-reactive protein, neutrophil-lymphocyte ratio and cardiac Troponin level was in group A than those in group B within postoperative 24 hours(P < 0.05).
CONCLUSIONS: The analysis of present study indicated despite relatively longer cardiopulmonary bypass time, the totally thoracoscopic mitral valve procedure seemed to be favorable with regard to the extent of inflammatory reaction, cardiac injury and postoperative recovery compared with conventional median sternotomy.

Entities:  

Keywords:  Cardiopulmonary bypass; biomarkers; minimally invasive surgical procedures; mitral valve; thoracoscopy

Mesh:

Year:  2020        PMID: 32064986     DOI: 10.1080/08941939.2020.1726531

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  4 in total

1.  The impact of medical insurance reimbursement on postoperative inflammation reaction in distinct cardiac surgery from a single center.

Authors:  Qin Jiang; Tao Yu; Keli Huang; Xiaobo Huang; Qingfeng Zhang; Shengshou Hu
Journal:  BMC Health Serv Res       Date:  2022-04-13       Impact factor: 2.655

Review 2.  Minimally invasive mitral valve surgery.

Authors:  Yasir Abu-Omar; Ibrahim T Fazmin; Jason M Ali; Marc P Pelletier
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

Review 3.  Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation.

Authors:  Qin Jiang; Keli Huang; Fang Lu; Shaoping Deng; Zhenglin Yang; Shengshou Hu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-09-12

4.  Total Thoracoscopic versus Robotic Surgery for Repair of Atrial Septum Defect: A Propensity Matching Score Analysis.

Authors:  Yanyi Liu; Zhuang Liu; Xin Li; Ning Li; Ruirui Kong; Yiyao Jiang; Shenglin Ge; Chengxin Zhang
Journal:  Emerg Med Int       Date:  2022-09-23       Impact factor: 1.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.